Issue: February 2016
January 11, 2016
4 min read
Save

Society updates listing criteria for heart transplantation

Issue: February 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The International Society for Heart and Lung Transplantation has issued an update to its criteria for listing for heart transplantation.

Perspective from Frank Smart , MD

The new guideline, an update of one from 2006, relaxed some of the recommendations of the older document in light of new evidence.

“There are many controversial issues in the guidelines that we have tackled head on, including heart transplantation in previously denied conditions (HIV, hepatitis amyloidosis, certain congenital heart diseases) that we now allow or recommend more lenient listing,” Mandeep R. Mehra, MD, professor of medicine at Harvard Medical School, medical director of the Heart and Vascular Center at Brigham and Women’s Hospital, editor-in-chief of The Journal of Heart and Lung Transplantation and chair of the task force that wrote the document, said in a press release. “The 2006 guidelines were particularly important in that we recommended against an age limit for transplantation or time dependency for patients with previously healed cancers. … The new guidelines not only update several of these prior issues, but also tackle the most controversial topics of our times.”

In one change, the task force now recommends that physicians suggest a weight-loss program for overweight patients with HF to a target BMI of less than 35 kg/m2, a change from the previous target BMI of less than 30 kg/m2. “BMI in the obese range but < 35 kg/m2 has not been convincingly associated with an increase in mortality after transplantation,” they wrote.

The guideline no longer recommends listing patients solely on the criteria of HF survival prognostic scores, such as the Seattle Heart Failure Model and the Heart Failure Survival Score, because concerns about their accuracy have been raised.

Periodic right-heart catheterization, a routine procedure for adult candidates for transplantation, is no longer recommended for children who may need transplantation, the authors wrote.

A new recommendation is that “use of [mechanical circulatory support] should be considered for patients with potentially reversible or treatable comorbidities, such as cancer, obesity, renal failure, tobacco use and pharmacologically irreversible pulmonary hypertension, with subsequent re-evaluation to establish candidacy” for heart transplantation.

The new document emphasizes the issue of social support after transplantation, recommending that patients without adequate social support to achieve compliant care as an outpatient “may be regarded as having a relative contraindication to transplant.” The authors wrote that the benefit of heart transplantation in patients with severe cognitive-behavioral disabilities or dementia has not been established and could produce harm, so these patients should not be considered candidates.

A new recommendation is that some patients with HIV infection, hepatitis, Chagas disease or tuberculosis may now be considered candidates for heart transplantation, assuming certain protocols are followed carefully. – by Erik Swain

Disclosure: Disclosures and conflicts of interest for all authors have been reviewed, declared and recorded with the International Society for Heart and Lung Transplantation office.